SCHEMBL4971964

SCHEMBL4971964

CC(CO)N(C(=O)OC(C)(C)C)C1CCC(F)(F)CC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ASGR1 P07306 1/20 0.30
GLP1R P43220 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971967 1.00 ASGR1 (0.30) ASGR1GLP1R
SCHEMBL4971669 0.85 EPHX1 (0.33)
SCHEMBL4971663 0.85 EPHX1 (0.33)
SCHEMBL4753063 0.84 EPHX1 (0.35)
SCHEMBL1424706 0.84 EPHX1 (0.35)
SCHEMBL4971528 0.82 PER2 (0.30)
SCHEMBL8909370 0.80 CA12 (0.34)
SCHEMBL8909366 0.80 CA12 (0.34)
SCHEMBL19687202 0.77
SCHEMBL1058050 0.76 HSD11B1 (0.43) ASGR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed